Press Releases Keyword Search Year None20232022202120202019201820172016201520142013 September 25, 2023 Editas Medicine Reports Inducement Grants to New Chief Commercial and Strategy Officer September 25, 2023 Editas Medicine Strengthens Executive Leadership Team with Appointment of Caren Deardorf as Chief Commercial and Strategy Officer August 30, 2023 Editas Medicine Announces Upcoming Investor Events August 2, 2023 Editas Medicine Announces Second Quarter 2023 Results and Business Updates July 27, 2023 Editas Medicine and Azzur Group Expand Partnership to Accelerate Editas’ Manufacturing Capabilities for Advancing the EDIT-301 Program Through Approval to Commercialization July 26, 2023 Editas Medicine Announces Second Quarter 2023 Results Conference Call and Corporate Update July 25, 2023 Editas Medicine Reports Inducement Grant to New Chief Scientific Officer July 24, 2023 Editas Medicine Strengthens Executive Leadership Team with Appointment of Linda C. Burkly, Ph.D., as Chief Scientific Officer June 14, 2023 Editas Medicine Announces Pricing of Offering of Common Stock June 14, 2023 Editas Medicine Announces Offering of Common Stock Pagination Current page 1 Page 2 Page 3 Next page next › Last page last »
September 25, 2023 Editas Medicine Reports Inducement Grants to New Chief Commercial and Strategy Officer
September 25, 2023 Editas Medicine Strengthens Executive Leadership Team with Appointment of Caren Deardorf as Chief Commercial and Strategy Officer
July 27, 2023 Editas Medicine and Azzur Group Expand Partnership to Accelerate Editas’ Manufacturing Capabilities for Advancing the EDIT-301 Program Through Approval to Commercialization
July 26, 2023 Editas Medicine Announces Second Quarter 2023 Results Conference Call and Corporate Update
July 24, 2023 Editas Medicine Strengthens Executive Leadership Team with Appointment of Linda C. Burkly, Ph.D., as Chief Scientific Officer
